Search research articles
Contact Us
Filters
Showing results (341-350 of 509) with videos related to
Page
of 51
Sort By:
Annals of Surgical Oncology
|
August 17, 2022
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
Fulvio Borella, Stefano Cosma, Domenico Ferraioli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2017
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2020
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel, Olivier Mir, Jennifer Wallet, et al.
Oncoimmunology
|
July 4, 2012
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
Manuarii Manuel, Olivier Tredan, Thomas Bachelot, et al.
The Oncologist
|
December 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25
Coline Montégut, Claire Falandry, Saverio Cinieri, et al.
BMJ Open
|
June 21, 2019
ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol
Aude Lacourt, Brice Amadéo, Céline Gramond, et al.
Translational Oncology
|
November 18, 2021
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
Philippe A Cassier, Clémentine Peyramaure, Valery Attignon, et al.
Gynecologic Oncology
|
July 27, 2020
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)
Patrick Robelin, Michel Tod, Olivier Colomban, et al.
Bulletin Du Cancer
|
April 4, 2012
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]
Isabelle Ray-Coquard, Franck Chauvin, Eric Leblanc, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators
Dominik Denschlag, Florian Heitz, Jacobus Pfisterer, et al.
Page
of 51
Search research articles
Search
Showing results (341-350 of 509) with videos related to
Sort By:
Page
of 51
Annals of Surgical Oncology
|
August 17, 2022
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
Fulvio Borella, Stefano Cosma, Domenico Ferraioli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2017
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2020
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel, Olivier Mir, Jennifer Wallet, et al.
Oncoimmunology
|
July 4, 2012
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
Manuarii Manuel, Olivier Tredan, Thomas Bachelot, et al.
The Oncologist
|
December 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25
Coline Montégut, Claire Falandry, Saverio Cinieri, et al.
BMJ Open
|
June 21, 2019
ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol
Aude Lacourt, Brice Amadéo, Céline Gramond, et al.
Translational Oncology
|
November 18, 2021
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
Philippe A Cassier, Clémentine Peyramaure, Valery Attignon, et al.
Gynecologic Oncology
|
July 27, 2020
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)
Patrick Robelin, Michel Tod, Olivier Colomban, et al.
Bulletin Du Cancer
|
April 4, 2012
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]
Isabelle Ray-Coquard, Franck Chauvin, Eric Leblanc, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators
Dominik Denschlag, Florian Heitz, Jacobus Pfisterer, et al.
Page
of 51